Leveraging Clinical Pharmacology to Optimize Drug Development for Nonalcoholic Steatohepatitis (NASH) and Cholestatic Liver Diseases

Nicholas R. Harrison & Sarah Sheehan

Nicholas R. Harrison & Sarah Sheehan

Brief on the Challenges to Sustainable Antibiotic Development

Alternative Payment Models to Support Child Health & Development: How to Design and Implement New Models

Rachel Roiland, Elizabeth Singletary, Robert S. Saunders, Susan Dentzer, Nathaniel Counts, Nicole Pereira, Jared Schor, & Neal Halfon

Rachel Roiland, Elizabeth Singletary, Robert S. Saunders, Susan Dentzer, Nathaniel Counts, Nicole Pereira, Jared Schor, & Neal Halfon

COVID-19 Manufacturing for Monoclonal Antibodies (Updated August 2020)

Isha Sharma, Marta Wosińska, Adam Kroetsch, Haley Sullivan, and Mark McClellan

Isha Sharma, Marta Wosińska, Adam Kroetsch, Haley Sullivan, and Mark McClellan